PKD1 and prostate cancer: Having made this prediction for a mutation originating from a prostate cancer sample (Lindberg et al., 2013), potential deregulation between PKD1 and its substrate HSP27 is particularly notable, as its phosphorylation is closely related to androgen receptor function in prostate cancer (Hassan et al., 2009, Sundram et al., 2011).